Compare L3Harris Technologies Inc (LHX) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
L3Harris Technologies Inc vs Twist Bioscience Corp — how do they compare? L3Harris Technologies Inc trades at $236.97 (market cap $44.12B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: L3Harris Technologies Inc is far larger — about 4.4× Twist Bioscience Corp's market cap, and L3Harris Technologies Inc pays a 2.11% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold L3Harris Technologies Inc for 56 Days and Twist Bioscience Corp for 27 Days on average.
| LHX | TWST | |
|---|---|---|
Market Cap | $44.12B | $10.08B |
Volume | 1,202,852 | 4,229,037 |
Sector | Industrials | Health |
52-Week High | $378.48 | $205.00 |
52-Week Low | $233.63 | $25.45 |
Typical Hold Time | 56 Days | 27 Days |
Enterprise Value | $54.56B | $10.01B |
Dividend Yield | 2.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LHX trades at $236.92, up 1.41% today, with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with 7.34% net margin and $1.61B net income in 2025. Recent $6B THAAD contract win highlights defense sector strength, though multiple law firm investigations create investor uncertainty.
Outlook remains positive with analyst consensus target of $340 (44% upside), supported by defense budget tailwinds and projected 2026 revenue growth to $22.9B. Key risks include legal investigations and debt levels, but institutional buy ratings (73.5%) signal confidence in long-term defense contracting business model.
TWST trades at $152.05, down 2.31% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported Q2 2026 EPS of -$0.56, missing expectations, continuing a trend of losses despite revenue growth to $376.57M in 2025. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, driving investor optimism.
Outlook remains speculative with high valuation multiples (P/S 21.5, P/B 22.62) and persistent losses, but analyst consensus is bullish (73% buy ratings) with a $145.20 price target. Key risks include cash burn, competitive pressures, and reliance on AI-driven growth catalysts for profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About L3Harris Technologies Inc
L3Harris Technologies was created in 2019 from the merger of L3 Technologies and Harris, two defense contractors that provide products for the command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) market. The firm also has smaller operations serving the civil government, particularly the Federal Aviation Administration's communication infrastructure, and produces various avionics for defense and commercial aviation.
Read more on LHX →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
